![Pierre Saint-Mezard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Pierre Saint-Mezard
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Vaderis Therapeutics AG
![]() Vaderis Therapeutics AG BiotechnologyHealth Technology Vaderis Therapeutics AG is a clinical stage biotech company based in Basel, Switzerland. The Swiss company aims to develop medicinal treatments for rare and orphan diseases associated with vascular malformations. The company focuses on developing a medicine for the treatment of HHT and other diseases associated with vascular malformations. HHT is a rare disease that causes vascular overgrowth due to genetic mutations, and there are no drugs approved anywhere in the world that specifically treat it. The company was founded in 2019 by Nicholas Benedict, Pierre Saint-Mezard, and Damien Picard, and Nicholas Benedict has been the CEO since incorporation. Vaderis raised a series a financing from Medicxi and acquired a portfolio of allosteric Akt inhibitors from Almac Discovery Ltd.
6
| Holding Company | Biotechnology | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Pierre Saint-Mezard
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Operating Officer | |
FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Brown University | College/University | Undergraduate Degree | |
Imperial College London | College/University | Undergraduate Degree | |
Index Ventures SA
![]() Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
The University of Manchester | College/University | Masters Business Admin | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Graduate Degree | |
Versant Venture Management LLC
![]() Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
MDS Pharma Services (Canada)
![]() MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University College London | College/University | Doctorate Degree | |
Archimedes Pharma Ltd.
![]() Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
King's College London | College/University | Undergraduate Degree | |
Allecra Therapeutics GmbH
![]() Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Georgetown University School of Medicine | College/University | Doctorate Degree | |
Northern Biologics, Inc.
![]() Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
Medicxi Ventures (Jersey) Ltd.
![]() Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder | |
Gadeta BV
![]() Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member | |
Janpix Holdings, Inc.
![]() Janpix Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Janpix Holdings, Inc. engages in provision of research and experimental development on biotechnology. The company was founded by Patrick T. Gunning and Cortes Pierre and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Fore Biotherapeutics, Inc.
![]() Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Mediar Therapeutics, Inc.
![]() Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Vicebio Ltd. | Director/Board Member | ||
Redmind LLC | Chief Executive Officer | ||
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Kenta Biotech AG
![]() Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Biotechnology | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 16 |
Vereinigtes Königreich | 8 |
Schweiz | 6 |
Kanada | 3 |
Deutschland | 2 |
Sektoral
Health Technology | 14 |
Consumer Services | 8 |
Commercial Services | 4 |
Finance | 4 |
Health Services | 3 |
Operativ
Director/Board Member | 12 |
Corporate Officer/Principal | 9 |
Chief Executive Officer | 6 |
Founder | 6 |
Undergraduate Degree | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Rahul Ballal | 13 |
Giovanni Mariggi | 11 |
Nicholas Benedict | 8 |
Hedvika Lazar | 4 |
Nick Williams | 1 |
Damien Picard | 1 |
- Börse
- Insiders
- Pierre Saint-Mezard
- Unternehmensverbindungen